1 Therapeutic Vaccines Market Overview
1.1 Product Overview and Scope of Therapeutic Vaccines
1.2 Therapeutic Vaccines Segment by Type
1.2.1 Global Therapeutic Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Peptide Therapeutic Vaccine
1.2.3 Cell Therapeutic Vaccine
1.2.4 Nucleic Acid Therapeutic Vaccine
1.3 Therapeutic Vaccines Segment by Application
1.3.1 Global Therapeutic Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Oncotherapy
1.3.3 Hepatitis B
1.3.4 Tuberculosis
1.3.5 Herpes Simplex Virus
1.3.6 Others
1.4 Global Therapeutic Vaccines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Vaccines Revenue 2017-2028
1.4.2 Global Therapeutic Vaccines Sales 2017-2028
1.4.3 Therapeutic Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Therapeutic Vaccines Market Competition by Manufacturers
2.1 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global Therapeutic Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Therapeutic Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Therapeutic Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Therapeutic Vaccines Market Competitive Situation and Trends
2.5.1 Therapeutic Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Therapeutic Vaccines Players Market Share by Revenue
2.5.3 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Vaccines Retrospective Market Scenario by Region
3.1 Global Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Therapeutic Vaccines Market Facts & Figures by Country
3.3.1 North America Therapeutic Vaccines Sales by Country
3.3.2 North America Therapeutic Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Therapeutic Vaccines Market Facts & Figures by Country
3.4.1 Europe Therapeutic Vaccines Sales by Country
3.4.2 Europe Therapeutic Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Therapeutic Vaccines Sales by Region
3.5.2 Asia Pacific Therapeutic Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Therapeutic Vaccines Market Facts & Figures by Country
3.6.1 Latin America Therapeutic Vaccines Sales by Country
3.6.2 Latin America Therapeutic Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Therapeutic Vaccines Sales by Country
3.7.2 Middle East and Africa Therapeutic Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Therapeutic Vaccines Historic Market Analysis by Type
4.1 Global Therapeutic Vaccines Sales Market Share by Type (2017-2022)
4.2 Global Therapeutic Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global Therapeutic Vaccines Price by Type (2017-2022)
5 Global Therapeutic Vaccines Historic Market Analysis by Application
5.1 Global Therapeutic Vaccines Sales Market Share by Application (2017-2022)
5.2 Global Therapeutic Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global Therapeutic Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Northeast Biotherapeutics
6.1.1 Northeast Biotherapeutics Corporation Information
6.1.2 Northeast Biotherapeutics Description and Business Overview
6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio
6.1.5 Northeast Biotherapeutics Recent Developments/Updates
6.2 Agenus
6.2.1 Agenus Corporation Information
6.2.2 Agenus Description and Business Overview
6.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Agenus Therapeutic Vaccines Product Portfolio
6.2.5 Agenus Recent Developments/Updates
6.3 Vaccinogen Inc
6.3.1 Vaccinogen Inc Corporation Information
6.3.2 Vaccinogen Inc Description and Business Overview
6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Vaccinogen Inc Therapeutic Vaccines Product Portfolio
6.3.5 Vaccinogen Inc Recent Developments/Updates
6.4 CIMAB S.A
6.4.1 CIMAB S.A Corporation Information
6.4.2 CIMAB S.A Description and Business Overview
6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 CIMAB S.A Therapeutic Vaccines Product Portfolio
6.4.5 CIMAB S.A Recent Developments/Updates
6.5 Dendreon
6.5.1 Dendreon Corporation Information
6.5.2 Dendreon Description and Business Overview
6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Dendreon Therapeutic Vaccines Product Portfolio
6.5.5 Dendreon Recent Developments/Updates
6.6 Corixa
6.6.1 Corixa Corporation Information
6.6.2 Corixa Description and Business Overview
6.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Corixa Therapeutic Vaccines Product Portfolio
6.6.5 Corixa Recent Developments/Updates
6.7 AVAX Technologies
6.6.1 AVAX Technologies Corporation Information
6.6.2 AVAX Technologies Description and Business Overview
6.6.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AVAX Technologies Therapeutic Vaccines Product Portfolio
6.7.5 AVAX Technologies Recent Developments/Updates
7 Therapeutic Vaccines Manufacturing Cost Analysis
7.1 Therapeutic Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Therapeutic Vaccines
7.4 Therapeutic Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Therapeutic Vaccines Distributors List
8.3 Therapeutic Vaccines Customers
9 Therapeutic Vaccines Market Dynamics
9.1 Therapeutic Vaccines Industry Trends
9.2 Therapeutic Vaccines Market Drivers
9.3 Therapeutic Vaccines Market Challenges
9.4 Therapeutic Vaccines Market Restraints
10 Global Market Forecast
10.1 Therapeutic Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Therapeutic Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Therapeutic Vaccines by Type (2023-2028)
10.2 Therapeutic Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Therapeutic Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Therapeutic Vaccines by Application (2023-2028)
10.3 Therapeutic Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Therapeutic Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Therapeutic Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
